Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Bone Marrow Aspiration and Biopsy

  • Author: Trisha Wise-Draper, MD, PhD; Chief Editor: Emmanuel C Besa, MD  more...
 
Updated: Mar 31, 2015
 

Overview

The procedure known as trepanning, or trephination, of bone is the oldest surgical practice that continues to have clinical relevance in modern times. The method dates as far back as the Neolithic period and initially entailed the drilling of cranial bones as a form of medical intervention for headaches and mental illnesses. However it was not until 1905, when the Italian physician Pianese reported bone marrow infiltration by the parasite Leishmania, that this procedure was applied to clinical evaluation.[1]

Currently, inspection of bone marrow is considered one of the most valuable diagnostic tools for evaluating hematologic disorders.[2] Indications have included diagnosis, staging, and therapeutic monitoring for lymphoproliferative disorders such as chronic lymphocytic leukemia (CLL), Hodgkin and non-Hodgkin lymphoma, hairy cell leukemia, myeloproliferative disorders, myelodysplatic syndrome and multiple myeloma. Furthermore, evaluation of cytopenia,[3] thrombocytosis, leukocytosis, anemia, and iron status can be performed.

The application of bone marrow analysis has grown to incorporate other, nonhematologic, conditions. For example, in the investigation for fever of unknown origin (FUO), specifically in those patients with autoimmune deficiency syndrome (AIDS),[4] the marrow may reveal the presence of microorganisms, such as tuberculosis, Mycobacterium avium intracellulare (MAI) infections, histoplasmosis, leishmaniasis, and other disseminated fungal infections.

Furthermore, the diagnosis of storage diseases (eg. Niemann-Pick disease and Gaucher disease[5] ), as well as the assessment for metastatic carcinoma and granulomatous diseases (eg, sarcoidosis) can be performed. Bone marrow analysis may reveal toxic effects of certain offending medications or substances, such as alcohol, or nutritional deficiencies, such as copper/zinc or vitamin B12/folate.

Bone marrow analysis can also be performed in patients with idiopathic thrombocytopenia purpura (ITP), incidental elevated serum paraprotein levels, iron deficiency anemia, polycythemia vera, essential thrombocytosis, or infectious mononucleosis; but these conditions are often more appropriately diagnosed by routine laboratory evaluation.[6]

Bone marrow consists of stem cells, which are large, "primitive," undifferentiated cells supported by fibrous tissue called stroma. There are two main types of stem cells and thus, bone marrow consists of two types of cellular tissue. One type of stem cell is involved in producing blood cells, and the other is involved in producing stromal cells, which are responsible for the supporting stroma. For more information about the relevant anatomy, see Bone Marrow Anatomy.

Sampling of the marrow consists of aspiration of the cellular component, acquisition of tissue fragments, or both. Aspiration of the marrow (see the image below) has been primarily utilized for cytologic assessment, with analysis directed toward assessing the morphology and obtaining a differential cell count. Further sampling allows material to be directed toward other ancillary tests, such as cytogenetics, molecular studies, microbiologic cultures, immunohistochemistry, and flow cytometry.

Bone marrow aspiration. Bone marrow aspiration.

Biopsies, on the other hand, allow evaluation of the marrow’s overall cellularity, detection of focal lesions, and determination of the extent of infiltration by various pathologic entities.[7, 8, 9]

For patient education information, see the Osteoporosis Center and the Cancer Center, as well as Bone Marrow Biopsy.

Next

Preliminary Assessment

An initial review of the patient’s clinical background is necessary to determine whether a bone marrow evaluation is warranted.

Medical history

The medical history should include the following:

  • Travel history - Exposure to parasites (leishmaniasis), fungi (histoplasmosis, Cryptococcus), mycobacteria
  • Immune compromise or immune deficiency status - This may contribute to a high infection risk, as in patients with human immunodeficiency virus (HIV) infection, underlying autoimmune deficiency (eg, Wiskott Aldrich Syndrome), and/or the use of immunosuppressive agents
  • Risk of bone fragility - Previous surgeries, chemotherapy, and radiation therapy can increase the risk of bone fragility, as well as pathologic processes that may contribute to bone resorption (eg, osteoporosis, multiple myeloma)
  • Previous diagnosis of malignancies - These are a risk for metastasis to bone, especially breast and prostate cancer
  • Glycogen storage diseases
  • Risk for hematologic anomalies - Contributing factors include a patient's nutrition status, alcoholism, medications, and history of a coagulation factor deficiency
  • Allergies - Testing and/or knowledge of a patient's allergy status are preventive measures to the potential allergens exposed during bone marrow sampling, such as latex, anesthetics (eg, lidocaine), antiseptics (eg, povidone-iodine)

Clinical presentation

Perform a thorough physical examination to assess the patient for signs of malignancy, infections, lesions associated with hemorrhagic injury, as well as disorders of hemostasis and coagulation.

Laboratory tests should initially include a complete blood count (CBC), a reticulocyte count, peripheral blood smears, prothrombin time (PT)/international normalized ratio (INR), and activated partial thromboplastin time (aPTT).

Other studies take into account the clinical presentation and may consist of the following: serum iron studies, serum ferritin study, vitamin B12 and folate levels, peripheral flow cytometry, quantitative polymerase chain reaction (PCR) of known translocations (BCR-Abl, JAK-2), erythrocyte sedimentation rate (ESR), serum protein electrophoresis, platelet function studies, coagulation mixing study, fibrin D-dimers, serum fibrinogen levels, serum bilirubin levels, and radiographs.[10]

Obtain informed patient consent that provides procedural information and potential complications (eg, hemorrhage, infections, pain). This will minimize any apprehension that the patient may have.

Previous
Next

Collection Site

The safe and preferred sites for bone marrow aspiration and/or biopsy are described below.

Aspiration and biopsy

The posterior superior iliac crest (see the image below) is the most commonly employed site for reasons of safety, decreased risk of pain, and accessibility. The posterior superior iliac crest site is localized to the central crest area.

Patient position (posterior superior iliac crest). Patient position (posterior superior iliac crest).

The anterior superior iliac crest is an alternative site when the posterior iliac crest is unapproachable or unavailable as a result of infection, injury, or morbid obesity. The anterior superior iliac crest site is localized to the center prominence, under the lip of the crest. This location is generally not preferred, because of the dense cortical layer, which makes samples harder to obtain and smaller in size and creates a risk of a more painful event.

Aspiration only

The sternum is sampled only as a last resort in those older than 12 years and in those who are morbidly obese, but this should be avoided in highly agitated patients. To decrease the risk of penetrating the underlying soft-tissue organs, the sternal site is limited to a region that spans between the second and third intercostal spaces.

The tibia is sampled only for infants younger than 1 year, and the procedure is conducted with the patient under general anesthesia. This site is localized to the proximal anteromedial surface, below the tibial tubercle. The tibial location is not utilized in older patients because the marrow cellularity is not consistent.[7, 11]

Previous
Next

Procedure

Aspiration sampling is generally performed before marrow biopsy of the posterior or anterior iliac crest. The reason is that the biopsy technique induces elevated thromboplastic substances, and this leads to a reduction in the effectiveness of an aspiration sampling.[8, 12, 13]

Aspiration

The patient is placed in the lateral decubitus position, with the top leg flexed and the lower leg straight. Alternatively, the patient may be placed in the prone position. The iliac crest is palpated, and the preferred sampling site is marked with a pen.

Aseptic technique is employed, including sterile gloves and gown. The site is prepared with an antiseptic (eg, povidone-iodine or chlorhexidine gluconate), scrubbed, and draped, exposing only the site to be sampled. (See the images below.)

Skin preparation. Skin preparation.
Site preparation. Site preparation.

The skin and the underlying tissue to the periosteum are infiltrated with a local anesthetic (eg, approximately 10 mL of 1% lidocaine). A 10-mL syringe with a 25-gauge needle is used to inject an initial 0.5 mL directly under the skin, raising a wheal. A 22-gauge needle is used to penetrate deeper into the subcutaneous tissue and the underlying periosteum, an area roughly 1 cm in diameter. (See the image below.)

Local anesthetic injection. Local anesthetic injection.

The adequacy of the anesthesia is tested by gently prodding the periosteum with the tip of the needle and questioning the patient for any painful sensation. It is important to be aware of changes in the patient's comfort level throughout the procedure, not only to decrease the patient's anxiety level but also to minimize movements that may affect the efficacy of the procedure.

Having a family member present may help to alleviate the patient's anxiety. To ensure sufficient pain control is being managed well, the person performing the procedure should talk to the patient, discuss the steps taken throughout the process, and listen to the manner as well as the content of the patient's response.

A skin incision is made with a small surgical blade, through which the bone marrow aspiration needle, with a stylet locked in place, is inserted. (See the image below.)

Aspiration needle placement. Aspiration needle placement.

Once the needle contacts the bone, it is advanced by slowly rotating clockwise and counterclockwise until the cortical bone is penetrated and the marrow cavity is entered. Contact with the marrow cavity is usually noted by a sudden reduction in pressure. The depth of the penetration should not extend beyond an initial 1 cm. (See the image below.)

Bone marrow aspiration. Bone marrow aspiration.

Once within the marrow cavity, the stylet is removed. Using a 20-mL syringe, approximately 0.3 mL of bone marrow is aspirated. Aspirating more than 0.3 mL risks diluting the sample with peripheral blood and thus is not recommended.

The material collected for bone marrow slides is generally not mixed with an anticoagulant, and it is processed immediately by a technologist; this avoids any cellular morphologic artifacts. If there is to be a delay in slide preparation, place the sample in an EDTA (ethylenediaminetetraacetic acid) anticoagulant-containing tube, preferably a pediatric-sized tube to avoid exposure to excess anticoagulant.

If additional marrow is needed for ancillary studies, subsequent specimens are obtained by attaching a separate syringe, collecting 5 mL at a time. The samples are then transferred into an anticoagulant-containing tube that is appropriate to the requested study: heparin for cytogenetic analysis; either heparin or EDTA for immunophenotyping; formalin for a Cytoblock preparation; and, gluaraldehyde for ultrastructural examination.

The marrow needle is removed, and pressure is applied to the aspiration site with gauze until any bleeding has stopped (see Postprocedure Care).

Once the aspiration is completed, the specimen is processed by the hematopathology technician.

Bone marrow biopsy

Any of several needle models can be utilized; however, the Jamshidi needle is considered the most popular. This disposable needle is tapered at the distal end to help retain the specimen for improved extraction.

Patient preparation is carried out in the manner previously described for bone marrow aspiration. Some kits allow aspiration and biopsy to be done with the same needle, which is convenient for the patient. However, if the latter is used, it is important to change the needle position slightly to a different area of bone after aspiration is obtained. Otherwise, an aspiration artifact is created where the marrow has been aspirated out of the core.

The needle, with stylet locked in place, is held with the palm and index finger and repositioned so that a new insertion site is created for biopsy sampling. Once the needle touches the bone surface, the stylet is removed. (See the images below.)

Bone marrow biopsy. Jamshidi needle placement. Bone marrow biopsy. Jamshidi needle placement.
Bone marrow biopsy. Jamshidi needle placement. Bone marrow biopsy. Jamshidi needle placement.

With firm pressure applied, the needle is slowly rotated in an alternating clockwise-counterclockwise motion and advanced into the bone marrow cavity to obtain an adequate bone marrow specimen measuring approximately 1.6-3 cm in length.

The needle is rotated along its axis to help loosen the sample, pulled back approximately 2-3 mm, and then advanced again slightly, at a different angle, to help secure the specimen. After this procedure, the needle is slowly pulled out while being rotated in an alternating clockwise and counterclockwise motion.

The specimen is removed from the needle, and a probe is introduced through the distal cutting end. If the aspirate was unsuccessful (ie, a "dry tap"), the core biopsy may be used to make touch preparations (see Slide Preparation). This must be performed before the specimen is placed in formalin. Finally, the specimen is placed in formalin solution for histologic processing. (See the images below.)

Bone marrow biopsy specimen. Bone marrow biopsy specimen.
Bone marrow biopsy specimen. Bone marrow biopsy specimen.
Bone marrow biopsy specimen in fixative solution. Bone marrow biopsy specimen in fixative solution.

The marrow needle is removed, and pressure is applied to the site with gauze until any bleeding has stopped (see Postprocedure Care).

Aspiration at sternum

At this site, only aspiration is to be performed, and it is to be performed only on adolescent and adult patient populations.

The second to third intercostal level of the sternum is palpated, and the selected sample site is marked with a pen. The area chosen should be to one side of the midline because the marrow cellularity is considered to be diminished at that location.

The designated area is prepared with an antiseptic scrub and draped. Aseptic technique is employed, including sterile gloves and gown. Local anesthetic is used to infiltrate from the skin to the periosteum.

After small cut is made in the skin with a surgical blade, the aspiration needle, with the stylet locked in place, is inserted until the needle touches the bone. With the same technique described previously, the needle is advanced into the marrow cavity, the specimen obtained, and the needle then removed. At this site, unlike other sites, the attached guard is not to be removed; rather, it is adjusted to allow the maximum depth of needle penetration to 0.5 cm. This prevents needle slippage that can result in injury to the underlying mediastinal organs.

Again, core biopsies are not to be performed from the sternum.

Previous
Next

Unilateral Versus Bilateral Iliac Crest Biopsy

Controversy exists with regard to the application of bilateral iliac biopsies. However, some studies have indicated that this technique increases the probability of detecting focal lesions, as in the case of carcinoma and lymphoma staging, where 11-16% of cases may be missed with unilateral biopsies.[14]

Wang et al reported improved identification of bone malignancy in the following pathologic cases[15] :

  • Hodgkin disease (19.5% improvement)
  • Sarcomas (14%)
  • Carcinomas (11.5%)
  • Non-Hodgkin lymphoma (4.6%)

Unilateral iliac sampling was considered sufficient in patients diagnosed with multiple myeloma, chronic myeloproliferative disorders, and myelodysplastic syndromes.[15]

Previous
Next

Postprocedure Care

After the procedure, apply firm pressure for 5 minutes to several layers of sterile gauze placed over the wound site. Remove residual antiseptic to avoid further skin irritation by the solution.

If hemorrhage from the wound persists, then place the patient in the supine position, with gauze over the wound site, so that consistent pressure can be applied for a minimum of 30 minutes. Rarely, bleeding may be present; if that is the case, consider placing a pressure dressing, again with the patient in a supine position, for an additional 1 hour.[12]

Discharge the patient with orders that the wound dressing be maintained in a dry state for 48 hours. The wound site is to be checked frequently, and if persistent bleeding or worsening pain occurs, the patient must report these findings to the clinician’s office.

Previous
Next

Slide Preparation

This stage in bone marrow preparation should be performed by trained personnel, such as a hematopathology technician. Thin-spread preparations of aspiration-collected samples, placed onto glass slides, can be prepared in numerous ways, all of which have the aim to retain and evaluate marrow particles. These spicules of fat droplets (not prominently seen in pediatric cases) and fragmented bone are likely to have adherent cellular material and thus be a target for morphologic evaluation. (See the images below.)

Bone marrow aspiration and biopsy slide preparatio Bone marrow aspiration and biopsy slide preparation.
Bone marrow aspiration and biopsy slide preparatio Bone marrow aspiration and biopsy slide preparation.
Bone marrow aspiration and biopsy slides before st Bone marrow aspiration and biopsy slides before staining.

An aspirate smear (or wedge) is the simplest of the methods, similar in presentation to a peripheral blood smear. A drop of the acquired specimen is placed 1 cm from the edge that opposes the frosted "labeled" end, and with a second glass slide placed at a 30º angle, the sample is pushed toward the opposing side in one rapid smooth stroke. Excess sample can be removed by tilting the glass slide onto gauze or pipetting the extraneous fluid.

Squash (or crush) preparations are prepared on glass slides by placing marrow particles on a slide and pressing the particles with another slide. These preparations are used to better observe cellular interactions as the architecture of the marrow unit is preserved. One report has shown that the crush technique is better for evaluating the percentage composition of bone marrow cells, whereas the wedge technique may be better for identifying cellularity.[16]

The cover slip method produces samples that have been concentrated more than the squash preparation. The aspirate particles are selected from a petri dish and directly placed onto a glass cover slip. In a manner similar to the squash method, a second cover slip is gently applied to crush the sample. Each cover slip is then stained individually. Thus, enhanced removal of contaminating peripheral blood is performed, again with retention of the marrow unit architecture.

At times, biopsy touch prints are useful, especially if the aspirate is dry and the only sample available is the bone marrow biopsy. In touch preparations, the hematopathology technician gently touches the tissue fragment onto a glass slide; this can provide morphologic details similar to that of an aspirate.

Marrow particles can be collected in aggregate as a clot and processed in a similar manner to that of tissue. The solid component is concentrated by placing the specimen in a finely meshed bag that retains the tissue fragments but allows excess fluid to escape.

Standard stains used for the initial evaluation include Wright and May-Grunwald-Giemsa stains, which enhance cytologic detail. Other special stains can be utilized for various purposes, such as Prussian blue for iron in cases of suspected hemosiderosis or for the ringed sideroblasts of myelodysplastic syndromes. Myeloperoxidase, Sudan Black B, and leukocyte alkaline phosphatase are used in categorizing acute myeloid leukemias. Periodic acid-Schiff (PAS) stain enhances depiction of cells that are implicated in glycogen storage diseases.[6, 12, 17]

Previous
Next

Morbidity/Mortality

In 2002 the British Society of Haematology initiated an annual survey to assess the various types and incidence of bone marrow biopsy adverse events.[18] Bain summarized results of a 7-year (1995-2001) retrospective study and identified 26 adverse events among approximately 54,890 biopsies, with an overall annual incidence of 0.05%. The most common side effects, in order of decreasing frequency, were the following:

  • Hemorrhage
  • Needle breakage
  • Infections

Risk factors for hemorrhage included concurrent anticoagulation therapy or underlying myeloproliferative/myelodysplastic syndrome, in which platelet function was affected. Two cases were fatal and were attributed to sepsis and massive hemorrhage.[18]

Four years later, a prospective study by Bain revealed 15 adverse events in a single year, with an overall incidence of 0.07%, not significantly different from the previous study's results.[13] However, although hemorrhage was still considered the most commonly encountered side effect, this study revealed that pain, anaphylactic reaction, and fractures were prominent secondary consequences. Two fatalities, attributed to laceration of blood vessels, were reported from 20,323 bone marrow aspiration and biopsy procedures.[13]

Previous
Next

Special Concerns

Special concerns to be taken into account include the following:

  • General anesthesia is required for pediatric cases, some sternal bone marrow sampling cases, and in those patients who are highly anxious
  • Sternal bone marrow aspiration has a higher risk of complications than other sites due to the delicate bone structure (approximately 1 cm thick in adults); penetration of the underlying mediastinal organs can result in mediastinitis, pulmonary embolism, pneumothorax, cardiac tamponade, and cardiac tissue injury, and for these reasons, biopsies are not to be performed from the sternum
  • Awareness of anatomic variations and pathologies that may affect bone density (eg, osteoporosis, multiple myeloma) can prevent further complications and injuries
  • Thrombocytopenia is not a contraindication to bone marrow aspiration and biopsy
  • Corrective action is required for coagulation disorders before bone marrow sampling
  • Application of sterile techniques is required in the prevention of infections
  • Dry tap, or the lack of specimen obtainment during the aspiration sampling process, is most commonly due to technical problems such as misalignment of the needle; other conditions that should be considered and may contribute to the decision of obtaining a biopsy are recent radiation therapy exposure, aplastic anemia, myelofibrosis, or bone infiltrative neoplasm
  • Knowing that tissue shrinkage can occur at an approximate rate of 25% after processing, the desired biopsy sampling size should initially be greater than 1.5 cm, preferably 2-3 cm in length (pediatric samples may be as small as 0.5 cm); such a size will allow evaluation of five or six intertrabecular spaces, which is considered sufficient sampling for a diagnosis [7, 8, 19]
  • Rarely, chronic pain may occur at the site of bone marrow sampling, thus necessitating further clinical management

Medicolegal pitfalls to be avoided include the following:

  • Failure to prevent, recognize, or initiate rapid response to excessive bleeding or, rarely, to an anaphylaxis anesthetic event during the bone marrow sampling procedure
  • Failure to use proper safety techniques, such as having a guard device to prevent needle slippage, specifically during sternal aspiration.
  • Failure to identify complications in sampling an iliac crest that results in penetration of the underlying gastrointestinal tract, as well as of blood vessels (which runs the risk of the development of massive retroperitoneal hemorrhage and gluteal compartment syndrome [20] )
Previous
 
Contributor Information and Disclosures
Author

Trisha Wise-Draper, MD, PhD Fellow in Hematology and Oncology, University of Cincinnati Medical Center; Research Fellow, The Division of Experimental Hematology and Cancer Biology, The Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center

Trisha Wise-Draper, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians

Disclosure: Nothing to disclose.

Coauthor(s)

Dimitrios Vergidis, MD Head, Department of Hematology and Medical Oncology, Northwestern Ontario Regional Cancer Centre; Clinical Associate Professor, Department of Medicine, McMaster University School of Medicine, Canada

Dimitrios Vergidis, MD is a member of the following medical societies: Alberta Medical Association, American Society of Hematology, Canadian Society of Internal Medicine, College of Physicians and Surgeons of Alberta, College of Physicians and Surgeons of Ontario, Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Ronald A Sacher, MB, BCh, FRCPC, DTM&H Professor, Internal Medicine and Pathology, Director, Hoxworth Blood Center, University of Cincinnati Academic Health Center

Ronald A Sacher, MB, BCh, FRCPC, DTM&H is a member of the following medical societies: American Association for the Advancement of Science, American Association of Blood Banks, American Society for Clinical Pathology, American Society of Hematology, College of American Pathologists, International Society on Thrombosis and Haemostasis, Royal College of Physicians and Surgeons of Canada, American Clinical and Climatological Association, International Society of Blood Transfusion

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: GSK Pharmaceuticals,Alexion,Johnson & Johnson Talecris,,Grifols<br/>Received honoraria from all the above companies for speaking and teaching.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Emmanuel C Besa, MD Professor Emeritus, Department of Medicine, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University

Emmanuel C Besa, MD is a member of the following medical societies: American Association for Cancer Education, American Society of Clinical Oncology, American College of Clinical Pharmacology, American Federation for Medical Research, American Society of Hematology, New York Academy of Sciences

Disclosure: Nothing to disclose.

Additional Contributors

Koyamangalath Krishnan, MD, FRCP, FACP Dishner Endowed Chair of Excellence in Medicine, Professor of Medicine, James H Quillen College of Medicine at East Tennessee State University

Koyamangalath Krishnan, MD, FRCP, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, American Society of Hematology, Royal College of Physicians

Disclosure: Nothing to disclose.

Acknowledgements

Corinne Goldberg, MD Fellow in Transfusion Medicine/Blood Banking, Transfusion Medicine Department, Hoxworth Blood Center, University of Cincinnati

Disclosure: Nothing to disclose.

References
  1. Parapia LA. Trepanning or trephines: a history of bone marrow biopsy. Br J Haematol. 2007 Oct. 139(1):14-9. [Medline].

  2. Fend F, Tzankov A, Bink K, et al. Modern techniques for the diagnostic evaluation of the trephine bone marrow biopsy: methodological aspects and applications. Prog Histochem Cytochem. 2008. 42(4):203-52. [Medline].

  3. Desalphine M, Bagga PK, Gupta PK, Kataria AS. To evaluate the role of bone marrow aspiration and bone marrow biopsy in pancytopenia. J Clin Diagn Res. 2014 Nov. 8(11):FC11-5. [Medline]. [Full Text].

  4. Quesada AE, Tholpady A, Wanger A, Nguyen AN, Chen L. Utility of bone marrow examination for workup of fever of unknown origin in patients with HIV/AIDS. J Clin Pathol. 2015 Mar. 68(3):241-5. [Medline].

  5. Sokolowska B, Skomra D, Czartoryska B, Tomczak W, Tylki-Szymanska A, Gromek T, et al. Gaucher disease diagnosed after bone marrow trephine biopsy - a report of two cases. Folia Histochem Cytobiol. 2011. 49(2):352-6. [Medline].

  6. Mazzella FM, Perrotta G. Peripheral blood and bone marrow. Schumacher HR, Rock WA, Stass SA, eds. Handbook of Hematologic Pathology. New York, NY: Marcel Dekker, Inc.; 2000. 1-26.

  7. Bain BJ. Bone marrow trephine biopsy. J Clin Pathol. 2001 Oct. 54(10):737-42. [Medline]. [Full Text].

  8. Trewhitt KG. Bone marrow aspiration and biopsy: collection and interpretation. Oncol Nurs Forum. 2001 Oct. 28(9):1409-15; quiz 1416-7. [Medline].

  9. Wilkins BS. Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis. J Clin Pathol. 2011 May. 64(5):380-6. [Medline].

  10. Bain BJ. Bone marrow aspiration. J Clin Pathol. 2001 Sep. 54(9):657-63. [Medline]. [Full Text].

  11. Knowles S, Hoffbrand AV. Bone-marrow aspiration and trephine biopsy (1). Br Med J. 1980 Jul 19. 281(6234):204-5. [Medline]. [Full Text].

  12. Riley RS, Hogan TF, Pavot DR, et al. A pathologist's perspective on bone marrow aspiration and biopsy: I. Performing a bone marrow examination. J Clin Lab Anal. 2004. 18(2):70-90. [Medline].

  13. Bain BJ. Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004. Haematologica. 2006 Sep. 91(9):1293-4. [Medline]. [Full Text].

  14. Barekman CL, Fair KP, Cotelingam JD. Comparative utility of diagnostic bone-marrow components: a 10-year study. Am J Hematol. 1997 Sep. 56(1):37-41. [Medline]. [Full Text].

  15. Wang J, Weiss LM, Chang KL, et al. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer. 2002 Mar 1. 94(5):1522-31. [Medline]. [Full Text].

  16. Lewandowski K, Kowalik MM, Pawlaczyk R, Rogowski J, Hellmann A. Microscopic examination of bone marrow aspirate in healthy adults - comparison of two techniques of slide preparation. Int J Lab Hematol. 2012 Jun. 34(3):254-61. [Medline].

  17. Perkins SL. Examination of the blood and bone marrow. Greer JP, Foerster J, Lukens JN, et al, eds. Wintrobe's Clinical Hematology. 11th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2004. Vol 1: 3-25.

  18. Bain BJ. Bone marrow biopsy morbidity and mortality. Br J Haematol. 2003 Jun. 121(6):949-51. [Medline].

  19. Knowles S, Hoffbrand AV. Bone-marrow aspiration and trephine biopsy (2). Br Med J. 1980 Jul 26. 281(6235):280-1. [Medline]. [Full Text].

  20. Roth JS, Newman EC. Gluteal compartment syndrome and sciatica after bone marrow biopsy: a case report and review of the literature. Am Surg. 2002 Sep. 68(9):791-4. [Medline].

  21. Ellis LD, Jensen WN, Westerman MP. Needle biopsy of bone and marrow: an experience with 1,445 biopsies. Arch Intern Med. 1964 Aug. 114:213-21. [Medline].

 
Previous
Next
 
Patient position (posterior superior iliac crest).
Bone marrow tray.
Skin preparation.
Site preparation.
Local anesthetic injection.
Aspiration needle placement.
Bone marrow aspiration.
Bone marrow biopsy. Jamshidi needle placement.
Bone marrow biopsy. Jamshidi needle placement.
Bone marrow biopsy specimen.
Bone marrow biopsy specimen.
Bone marrow biopsy specimen in fixative solution.
Bone marrow aspiration and biopsy slide preparation.
Bone marrow aspiration and biopsy slide preparation.
Bone marrow aspiration and biopsy slides before staining.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.